Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

Journal of Clinical Oncology, Vol 22, No 15 (August 1), 2004: pp. 3039-3045
© 2004 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2004.08.177

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alpen, B.
Right arrow Articles by Neubauer, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alpen, B.
Right arrow Articles by Neubauer, A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Ongoing Monoclonal B-Cell Proliferation Is Not Common in Gastric B-Cell Lymphoma After Combined Radiochemotherapy

Birgit Alpen, Rolf Kuse, Radzak Parwaresch, Hans Konrad Müller-Hermelink, Manfred Stolte, Andreas Neubauer

From the Departments of Internal Medicine, Hematology, Oncology, and Immunology, Hospital of the Philipps-University, Marburg; Department of Hematology, St Georg Hospital, Hamburg; Institute for Hematopathology, University of Kiel, Kiel; Institute for Pathology, University of Würzburg, Würzburg; and Institute for Pathology, Hospital Bayreuth, Bayreuth, Germany

Address reprint requests to Andreas Neubauer, MD, Hospital of Philipps University, Department of Hematology, Oncology and Immunology, Baldinger Straße, 35033 Marburg, Germany; e-mail: neubauer{at}mailer.uni-marburg.de

PURPOSE: Gastric marginal-zone B-cell lymphoma (MZBCL) of the mucosa-associated lymphoid tissue (MALT) is associated with chronic Helicobacter pylori gastritis. Stable complete remission (CR) can be induced by H pylori eradication. Whether this is paralleled by cure of the lymphoma remains unclear. Persisting monoclonal bands for immunoglobulin heavy chain variable region (VH) representing the lymphoma clone have been described in up to 50% of patients in CR. This retrospective study investigated whether this phenomenon also occurs after radiochemotherapy.

PATIENTS AND METHODS: Biopsy samples of 20 patients receiving chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisone and irradiation were analyzed before and after therapy. Study patients had Ann Arbor stage I/II primary gastric cancer, including four cases of MZBCL of MALT type, 12 cases of diffuse large-cell lymphomas (DLCL), and four cases of mixed MALT type/DLCL. Polymerase chain reaction (PCR) for VH rearrangement was performed. Monoclonal PCR products were cloned and sequenced.

RESULTS: Fourteen of 20 patients had a monoclonal or oligoclonal band distribution at diagnosis converted into polyclonal pattern after radiochemotherapy. Of the remaining six patients, two were lost to follow-up. One patient did not respond and died of progressive disease. PCR in this patient showed persistent B-cell clonality. In three patients, the initial PCR showed a polyclonal pattern and thus could not be evaluated during follow-up.

CONCLUSION: In contrast with H pylori eradication alone, radiochemotherapy results in clearing of monoclonal cells during follow-up. This may result in better elimination of residual lymphoma cells. Further study is needed to determine whether this translates into lower risk of relapse.

Supported by the Deutsche Krebshilfe (grant No. 70-2251, Ne1).

Authors' disclosures of potential conflicts of interest are found at the end of this article.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
B. Streubel, D. Huber, S. Wohrer, A. Chott, and M. Raderer
Reverse Transcription-PCR for t(11;18)(q21;q21) Staging and Monitoring in Mucosa-Associated Lymphoid Tissue Lymphoma.
Clin. Cancer Res., October 15, 2006; 12(20): 6023 - 6028.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
T. Wundisch, C. Thiede, A. Morgner, A. Dempfle, A. Gunther, H. Liu, H. Ye, M.-Q. Du, T. D. Kim, E. Bayerdorffer, et al.
Long-Term Follow-Up of Gastric MALT Lymphoma After Helicobacter Pylori Eradication
J. Clin. Oncol., November 1, 2005; 23(31): 8018 - 8024.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. Mueller, J. O'Rourke, P. Chu, A. Chu, M. F. Dixon, D. M. Bouley, A. Lee, and S. Falkow
The Role of Antigenic Drive and Tumor-Infiltrating Accessory Cells in the Pathogenesis of Helicobacter-Induced Mucosa-Associated Lymphoid Tissue Lymphoma
Am. J. Pathol., September 1, 2005; 167(3): 797 - 812.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
A. Noy, J. Yahalom, L. Zaretsky, I. Brett, and A. D. Zelenetz
Gastric Mucosa-Associated Lymphoid Tissue Lymphoma Detected by Clonotypic Polymerase Chain Reaction Despite Continuous Pathologic Remission Induced by Involved-Field Radiotherapy
J. Clin. Oncol., June 1, 2005; 23(16): 3768 - 3772.
[Abstract] [Full Text] [PDF]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2004 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online